News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 17 abr 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News 01 nov 2023 Bacthera’s Visp plant aims to revolutionize microbiome-based treatments In Visp, Bacthera’s MC4a Center of Excellence readies to manufacture transformative microbiome therapies, notably the Seres Therapteutics’ life-s...
News 25 out 2023 Mecaplast Swiss, 50 years of innovation in the canton of Fribourg With a rich history spanning five decades, Mecaplast Swiss has consistently proven itself as a leader in the plastic injection industry, particul...
News 23 out 2023 Valsynthèse, 40 years of innovation in the canton of Valais From dynamite to pharmaceuticals, Valsynthèse, the 'fine chemistry' business unit of the Société Suisse des Explosifs, celebrates four decades of...
News 29 set 2023 Top Stories from Western Switzerland (July-September 2023) From spearheading eco-innovative solutions to pioneering breakthroughs in solar technology, cancer research, sustainable shipping, and the realms...
News 14 ago 2023 Bern’s thriving ecosystem for life sciences innovation In the heart of Western Switzerland, the canton of Bern has emerged as a location of choice for companies in the life sciences sector.
News 16 jun 2023 Saiba Animal Health issues license to Boehringer Ingelheim German pharmaceutical company Boehringer Ingelheim has secured an exclusive license for a Saiba Animal Health product candidate. This is the seco...
News 08 mar 2023 Bachem receives order totaling more than 500 million Swiss francs Bachem has signed a long-term cooperation agreement for the development and production of peptides. It includes a binding order volume of more th...
News 01 fev 2023 SSE Group and Hypex Bio join forces for an environmentally friendly explosive solution The Société Suisse des Explosifs (SSE) has entered into a partnership with Swedish company Hypex Bio Explosives Technology to market its new envi...
News 18 jan 2023 Calciscon enters Eurostars project to improve patient care worldwide Calciscon, together with Amsterdam University Medical Centers and ADMESY, have signed a collaborative agreement for the development of a laborato...